The agency could by late December approve a therapy that Roche sees as potentially becoming a new treatment standard for ...
Madrigal shares fell 11% despite again topping consensus sales numbers. Elsewhere, Daiichi Sankyo named a new research chief ...
In a 6-3 decision, the court rejected President Trump's claim that a 1977 law gave him the authority to impose broad tariffs ...
Despite a wave of AI-fueled layoffs, the pharma and biotech industries could be spared from massive cutbacks for now.
Shares in the company lost about half their value in Friday trading after use of the test wasn’t associated with a statistically significant reduction in late-stage cancer diagnoses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results